1. Home
  2. RKDA vs CANF Comparison

RKDA vs CANF Comparison

Compare RKDA & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$2.13

Market Cap

3.0M

Sector

Industrials

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.99

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
CANF
Founded
2002
1994
Country
United States
Israel
Employees
9
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RKDA
CANF
Price
$2.13
$3.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9,750.00
AVG Volume (30 Days)
23.2K
532.6K
Earning Date
11-07-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,173,000.00
$560,000.00
Revenue This Year
$21.31
$461.72
Revenue Next Year
$28.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.31
N/A
52 Week Low
$1.76
$3.36
52 Week High
$6.71
$46.60

Technical Indicators

Market Signals
Indicator
RKDA
CANF
Relative Strength Index (RSI) 26.43 88.71
Support Level $1.76 $0.17
Resistance Level $3.50 $4.59
Average True Range (ATR) 0.31 0.11
MACD -0.14 0.39
Stochastic Oscillator 12.25 85.51

Price Performance

Historical Comparison
RKDA
CANF

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

Share on Social Networks: